Cell IDx was founded to be the technology leader in multiplexed cellular immunodiagnostics. We are a privately held biotechnology company committed to developing highly sensitive and specific reagents for research and clinical immunohistochemistry and other immunoassays. Our platform multiplex immunofluorescence technology allows multiplexing of 4 or more antibodies, even from the same species and permits detection of multiple co-localized targets on a single tissue section. We are a full service company offering custom multiplex panel development, sectioning, staining, imaging and image analysis.